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Introduction
Polychlorinated biphenyls (PCBs) and 
dioxins are ubiquitous persistent organic 
pollutants (POPs). PCBs were once widely 
manufactured and used as coolants or lubri-
cants, whereas dioxins were unintention-
ally produced as industrial byproducts in a 
variety of commercial and industrial settings 
[Agency for Toxic Substances and Disease 
Registry (ATSDR) 1994, 1998]. Although 
PCB production and use were banned in the 
mid-1970s in the United States, most people 
continue to be exposed at low levels through 
food (ATSDR 1994, 1998, 2000). Exposure 
to dioxins and dioxin-like compounds is 
associated with overall cancer risk, although 
the carcinogenic mechanisms remain poorly 
understood [International Agency for 
Research on Cancer (IARC) 2012]. Dioxins 
may increase the risk for lung cancer, soft-
tissue sarcoma, and non-Hodgkin lymphoma 
(IARC 2012). PCBs are also likely carcino-
gens and may raise cancer risk for melanoma 
as well as for cancers of the liver, intestines, 
and biliary tract (ATSDR 2000).
Telomeres are noncoding segments of 
DNA at the ends of chromosomes (Calado 
and Young 2009). Because telomeres are 
shortened with every cell division, eventu-
ally reaching a critical length that triggers cell 
senescence, they are considered a measure 
of cellular aging (Calado and Young 2009; 
Cong et al. 2002). Although telomeres 
typically shorten over the lifetime of a cell, 
under certain circumstances, telomeres may 
instead be lengthened. Telomerase, which 
is composed of subunits TERT (telomerase 
reverse transcriptase) and TERC (rRNA 
component of telomerase), can synthesize 
new telomere DNA sequences, thereby 
elongating telomeres (Cong et al. 2002). In 
normal somatic adult cells, telomerase expres-
sion is very low or undetectable, but telom-
erase is frequently expressed in immortalized 
or cancerous cells (Cong et al. 2002; Sarkar 
et al. 2006).
Leukocyte telomere length (LTL) is 
sometimes measured in epidemiological 
studies as a proxy for whole-organism 
telomere length. In epidemiological studies, 
short LTL has been associated with increased 
risk for a variety of chronic conditions, 
including cardiovascular disease (Haycock 
et al. 2014), Type II diabetes (Willeit et al. 
2014), and metabolic syndrome (Révész et al. 
2014). Therefore, it has been suggested that 
LTL may act as a measurable biomarker not 
only for cellular aging but also for organismal 
aging (Aubert and Lansdorp 2008).
Exposure to some environmental chemi-
cals may affect LTL, and both positive and 
inverse associations have been reported in 
the literature. Exposure to cadmium, lead, 
polycyclic aromatic hydrocarbons, and traffic 
pollution have all been associated with short 
LTL (Hoxha et al. 2009; Zhang et al. 2013; 
Zota et al. 2015). Arsenic and particulate 
matter have also been associated with LTL, 
although the direction of the association 
depends on the dose or duration of exposure 
(Ferrario et al. 2009; Hou et al. 2012; Zhang 
et al. 2013). Finally, benzene exposure 
has been associated with increased LTL 
in occupationally exposed workers (Bassig 
et al. 2014). Because exposure to some toxic 
environmental chemicals is associated with 
increased LTL, the relationship between envi-
ronmental chemicals, LTL, and overall health 
is likely complex.
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Background: Exposure to persistent organic pollutants (POPs) such as dioxins, furans, and 
polychlorinated biphenyls (PCBs) may influence leukocyte telomere length (LTL), a biomarker 
associated with chronic disease. In vitro research suggests dioxins may bind to the aryl hydrocarbon 
receptor (AhR) and induce telomerase activity, which elongates LTL. However, few epidemiologic 
studies have investigated associations between POPs and LTL.
oBjectives: We examined the association between 18 PCBs, 7 dioxins, and 9 furans and LTL 
among 1,330 U.S. adults from NHANES 2001–2002.
Methods: We created three summed POP metrics based on toxic equivalency factor (TEF), 
a potency measure including affinity for the AhR: a) non–dioxin-like PCBs (composed of 
10 non–dioxin-like PCBs; no AhR affinity and no TEF); b) non-ortho PCBs (composed of 
2 non–ortho-substituted PCBs with high TEFs); and c) toxic equivalency (TEQ) (composed of 
7 dioxins, 9 furans, 2 non–ortho-substituted PCBs, and 6 mono–ortho-substituted PCBs; weighted 
by TEF). We tested the association between each metric and LTL using linear regression, adjusting 
for demographics, blood cell count and distribution, and another metric with a different TEF (i.e., 
non-ortho PCBs and TEQ adjusted for non–dioxin-like PCBs; non–dioxin-like PCBs adjusted for 
non-ortho PCBs).
results: In adjusted models, each doubling of serum concentrations of non-ortho PCBs and TEQ 
was associated with 3.74% (95% CI: 2.10, 5.40) and 5.29% (95% CI: 1.66, 9.05) longer LTLs, 
respectively. Compared with the lowest quartile, the highest quartile of exposure was associated 
with 9.16% (95% CI: 2.96, 15.73) and 7.84% (95% CI: –0.53, 16.92) longer LTLs, respectively. 
Non–dioxin-like PCBs were not associated with LTL.
conclusions: POPs with high TEFs and AhR affinity were associated with longer LTL. Because 
many dioxin-associated cancers are also associated with longer LTL, these results may provide 
insight into the mechanisms underlying PCB- and dioxin-related carcinogenesis.
citation: Mitro SD, Birnbaum LS, Needham BL, Zota AR. 2016. Cross-sectional associa-
tions between exposure to persistent organic pollutants and leukocyte telomere length among 
U.S. adults in NHANES, 2001–2002. Environ Health Perspect 124:651–658; http://dx.doi.
org/10.1289/ehp.1510187
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Despite the evidence of associations with 
other environmental chemicals, only one 
epidemiologic study has investigated the rela-
tionship between PCBs and LTL. That study, 
a cross-sectional analysis of 84 Korean adults, 
reported an association between exposure to 
PCBs and longer LTL. However, the study 
did not account for the possible confounding 
effect of simultaneous exposure to multiple 
different PCB congeners, nor did the study 
measure exposure to dioxins (Shin et al. 
2010). It remains unclear whether this asso-
ciation would also be seen in a population-
based study with more complete control for 
confounders and whether exposure to dioxins 
is also associated with longer LTL.
Although no prior epidemiologic study 
has examined the effects of dioxin exposure 
on LTL, some preliminary in vitro findings 
suggest a possible role for telomerase and 
telomere length in dioxin-mediated carcino-
genesis. In one in vitro study using human 
choriocarcinoma cells, TERT expression 
(and therefore telomerase) was up-regulated 
in cells treated with dioxin (Sarkar et al. 
2006). Because dioxins are potent aryl hydro-
carbon receptor (AhR) agonists (Chopra and 
Schrenk 2011), the authors of that study 
suggested that telomerase up-regulation may 
be mediated via AhR activation (Sarkar et al. 
2006). Activated telomerase, which elongates 
telomeres, is thought to confer uncontrolled 
replicative ability on a cell (Ruden and Puri 
2013). Additionally, dioxins have been shown 
to immortalize human keratinocytes and to 
repress transcription of tumor suppressor 
genes p53 and p16INK4a in vitro (Ray and 
Swanson 2004).
In this analysis, we conducted a cross-
sectional study to examine the association 
between exposure to PCBs, dioxins, and 
furans and LTL, using a representative sample 
of U.S. adults from NHANES 2001–2002. 
We hypothesized that exposure to dioxins, 
furans, and PCBs would be associated with 
longer LTL. Additionally, we hypothesized 
that the association would be stronger for 
congeners with greater AhR affinity.
Methods
We used data from the 2001–2002 cycle 
of the National Health and Nutrition 
Examination Survey (NHANES) to examine 
the association between lipid-adjusted serum 
measurements of POPs (34 PCBs, 7 dioxins, 
and 9 furans) and relative LTL. NHANES is 
an ongoing series of cross-sectional national 
surveys conducted by the U.S. Centers for 
Disease Control and Prevention (CDC), 
including both physical examinations and 
questionnaires. NHANES uses probability-
based methods to obtain a sample that 
is representative of the noninstitutional-
ized population of the United States. All 
participants provide written informed consent, 
and the National Center for Health Statistics 
obtains institutional review board approval to 
conduct the surveys (Zipf et al. 2013).
Study Population
In the 2001–2002 cycle, 11,039 people were 
interviewed by NHANES. Stored samples 
were available and sufficient to estimate 
telomere length for 4,260 participants 
≥ 20 years of age who provided a blood sample 
and consented to the use of their DNA (78.7% 
of all interviewed participants ≥ 20 years of 
age). Women, individuals below the poverty 
level, individuals with at least a high school 
education, non-Hispanic blacks, and indi-
viduals over age 60 were less likely to consent 
to use of their DNA samples (McQuillan 
et al. 2006). From the population with suffi-
cient DNA samples to generate LTL data, we 
then excluded individuals without environ-
mental chemical analysis data (n = 2,850) or 
who were missing data on body mass index 
(BMI) (n = 70), education (n = 2), or serum 
cotinine (n = 8), leaving a study population of 




Serum spec imens  were  sp iked wi th 
13C12-labeled internal standards, and the 
dioxin or PCB congener was isolated in 
hexane using a C18 solid phase extraction. 
To isolate PCBs, samples were then extracted 
through neutral silica and Florosil SPE 
columns (CDC 2002a); to isolate dioxins, 
samples underwent Power-Prep/6 (Fluid 
Management Systems) automated cleanup 
and enrichment procedures using multi-
layered silica gel and alumina columns 
coupled to an AX-21 carbon column (CDC 
2002b). Dioxins were isolated in reverse 
direction from carbon using toluene (CDC 
2002b). Each analytical run of PCBs, dioxins, 
or furans was blinded and included blanks and 
quality-control samples. Before quantifying 
the PCB, dioxin, or furan in a sample, the 
sample was reconstituted with 13C12-labeled 
external standard. PCBs, dioxins, and furans 
were then measured using high-resolution 
gas chromatography/isotope-dilution high-
resolution mass spectrometry (CDC 2002a, 
2002b). Limits of detection (LOD) were 
reported for every sample. Samples with 
greater serum volume had lower detection 
limits (CDC 2002a, 2002b). Typically, detec-
tion limits were ~2 ng/g, although they could 
be as high as 10.5 ng/g (the LOD range for 
each chemical is reported in Table 1). The 
CDC replaced concentrations below the LOD 
with the sample-specific LOD divided by 
the square root of 2. Coefficients of variation 
ranged from 7.7 to 28 for the PCBs and from 
5.3 to 15.3 for the dioxins and furans, varying 
by congener and sample lot (CDC 2002a, 
2002b). Serum lipids were calculated using 
an enzymatic summation method (Akins 
et al. 1989).
Telomere Length Measurement
Aliquots of purified DNA were provided by 
the laboratory at the Division of Health and 
Nutrition Examination Surveys, National 
Center for Health Statistics, Centers for 
Disease Control and Prevention. DNA 
was extracted from whole blood using the 
Puregene (D-50K) kit protocol (Gentra 
Systems, Inc., Minneapolis, Minnesota) 
and stored at –80° C. The telomere length 
assay was performed in the laboratory of E. 
Blackburn (University of California, San 
Francisco), using the quantitative polymerase 
chain reaction (qPCR) method to measure 
telomere length relative to standard reference 
DNA (T/S ratio) (Cawthon 2002; Lin et al. 
2009). The telomere thermal cycling profile 
consisted of cycling for T (telomic) PCR: 
96°C for 1 min; denature at 96°C for 1 sec, 
anneal/extend at 54°C for 60 sec, with fluo-
rescence data collection, 30 cycles. Cycling 
for S (single copy gene) PCR consisted of the 
following: 96°C for 1 min; denature at 95°C 
for 15 sec, anneal at 58°C for 1 sec, extend at 
72°C for 20 sec, 8 cycles; followed by denature 
at 96°C for 1 sec, anneal at 58°C for 1 sec, 
extend at 72°C for 20 sec, hold at 83°C for 
5 sec with data collection, 35 cycles.
The primers for the telomere PCR were 
tel1b [5´-CGG TTT (GTTTGG)5 GTT-3´], 
used at a final concentration of 100 nM, and 
tel2b [5´-GGC TTG (CCTTAC)5 CCT-3´], 
used at a final concentration of 900 nM. The 
primers for the single-copy gene (human 
beta-globin) PCR were hbg1 (5´ GCT TCT 
GAC ACA ACT GTG TTC ACT AGC-3´), 
used at a final concentration of 300 nM, 
and hbg2 (5´-CAC CAA CTT CAT CCA CGT 
TCACC-3´), used at a final concentration of 
700 nM. The final reaction mix contained 
20 mM Tris-hydrochloride (HCl), pH 8.4; 
50 mM potassium chloride (KCl); 200 μM 
each deoxynucleotide (dNTP); 1% dimethyl 
sulfoxide (DMSO); 0.4× SYBR Green I; 22 
ng Escherichia coli DNA per reaction; and 
0.4 units of Platinum Taq DNA polymerase 
(Invitrogen Inc.) per 11-μL reaction.
Each sample was assayed three times in 
duplicate wells, producing six data points. 
The mean T/S ratio values were calculated, 
and the T/S ratio that differed most from the 
mean for the group of replicates was marked 
as a potential outlier. The mean was calcu-
lated a second time, excluding the potential 
outlier. The potential outlier was determined 
to be a true outlier if the absolute value of the 
log of the ratio between the recalculated mean 
(excluding the potential outlier) and the value 
PCBs, dioxins, and telomere length in NHANES
Environmental Health Perspectives • volume 124 | number 5 | May 2016 653
of the potential outlier was greater than 0.4 
(98.7% of all samples contained no outliers) 
(Needham et al. 2013). DNA samples were 
coded, and the lab was blinded to all other 
measurements in the study. The CDC 
conducted a quality control review before 
linking the telomere data to the NHANES 
1999–2002 public use data files.
Statistical Analysis
Based on in vivo evidence of toxicity, the 
World Health Organizat ion (WHO) 
assigned each congener a toxic equivalency 
factor (TEF), a measure of relative potency 
compared with that of reference chemical 
2,3,7,8-tetrachlorodibenzo-p-dioxin (Van den 
Berg et al. 2006). Because the TEF is partially 
based on AhR affinity, we used each conge-
ner’s TEF (according to the WHO 2005 
summary) as a proxy for affinity for the AhR 
in order to group congeners by expected effect 
(Van den Berg et al. 2006).
After excluding congeners detected in 0% 
of samples (PCB-81 and 1,2,3,4,6,7,8,9-octa-
chlorodibenzofuran) and PCBs without AhR 
affinity that were detected in less than 50% 
of samples (PCBs 52, 66, 87, 101, 110, 128, 
146, 149, 151, 172, 177, 178, 183, 195, 
and 206), we created three summary metrics 
with varying TEFs from lipid-adjusted serum 
measurements of the POPs: non–dioxin-like 
PCBs, non-ortho PCBs, and toxic equiva-
lent (TEQ). Before summing, all pollutant 
concentrations were converted to picograms 
per gram lipid to account for individual 
differences in serum lipids because dioxins 
distribute to the lipid fraction of blood 
(Schisterman et al. 2005).
The non–dioxin-like PCB metric was 
created by summing the lipid-corrected 
concentrations of 10 PCBs with no TEFs and 
no AhR affinity (PCBs 74, 99, 138, 153, 170, 
180, 187, 194, 196, and 199; TEF value range 
0.0–0.0) (Table 1) (Van den Berg et al. 2006). 
The non-ortho PCB metric was the sum of the 
lipid-corrected concentrations of 2 non–ortho-
substituted PCBs, which had high TEFs and 
high AhR affinity (PCBs 126 and 169; TEF 
value range 0.03–0.10) (Table 1) (Van den 
Berg et al. 2006). The TEQ metric was the 
sum of the lipid-corrected concentrations of 
7 chlorinated dibenzo-p-dioxins, 9 dibenzo-
furans, 2 non–ortho-substituted PCBs, and 
6 mono–ortho-substituted PCBs, weighted 
using TEFs from the WHO 2005 summary in 
the following manner: TEQ = ∑[(congener’s 
TEF) × (congener’s concentration)] (TEQ 
value range 0.0003–1.0) (Table 1) (Van den 
Berg et al. 2006). Although the non–ortho-
substituted PCBs were included in both the 
non-ortho PCB metric and the TEQ metric, 
the non-ortho PCB metric was created without 
weighting, whereas the TEQ was weighted 
using TEF values. Only participants with 
complete data on all congeners in a metric 
were included in the metric. All metrics were 
natural log–transformed to account for their 
nonnormal distributions.
To estimate the association between 
pollutants and LTL, the metrics were modeled 
continuously and in quartiles. Quartiles 
were calculated using a weighted distribu-
tion based on NHANES population weights. 
Additionally, a test for trend was performed 
by modeling the integer value of each quartile 
(i.e., 0, 1, 2, 3) as an ordinal term and using 
its p-value as a test of departures from the null 
hypothesis of no linear trend.
We used multivariable linear regression 
models to assess the relationship between 
serum levels of POPs and relative LTL. 
Covariates were selected a priori based on 
factors shown to be associated with LTL in 
this population (Needham et al. 2013; Zota 
et al. 2015). Two multivariable models were 
used. The first model was adjusted for age 
(continuous) and age2 (continuous). The 
second model was adjusted for age (contin-
uous), age2 (continuous), sex, race/ethnicity 
(non-Hispanic white, non-Hispanic black, 
Mexican American, other), educational 
attainment (less than high school, high 
school graduate, some college, college or 
more) BMI (< 25, 25–29.9, ≥ 30), smoking 
(natural log–transformed cotinine), and blood 
cell count and distribution (white blood cell 
count, percent lymphocytes, percent mono-
cytes, percent neutrophils, percent eosino-
phils, percent basophils). Blood cell count 
and distribution variables were included 
because LTL is measured in immune cells 
and because blood cell count and distribution 
are associated with serum PCBs (Serdar et al. 
2014). We estimated the percent difference 
in LTL for a doubling of exposure concen-
tration as [e(ln2 × β) – 1] × 100%, with the 
95% confidence inverval (CI) estimated 
as {e[ln2 × (β ± 2.131 × SE)] – 1} × 100%. For 
Table 1. LOD and weights used in metrics. 








PCB-74 1,323 1.6–10.5 67.7 1.0
PCB-99 1,301 < 2.8–10.5 62.6 1.0
PCB-105 1,323 1.6–10.5 21.3 0.00003
PCB-118 1,323 2.8–10.5 73.1 0.00003
PCB-126 1,137 1.8–10.5 88.0 1.0 0.1
PCB-138 1,319 3.0–10.5 93.3 1.0
PCB-153 1,323 3.0–10.5 96.3 1.0
PCB-156 1,317 1.6–10.5 54.0 0.00003
PCB-157 1,316 0.8–10.5 7.5 0.00003
PCB-167 1,317 < 1.3–10.5 10.8 0.00003
PCB-169 1,135 2.4–10.5 88.1 1.0 0.03
PCB-170 1,319 < 2.8–10.5 75.1 1.0
PCB-180 1,322 2.8–10.5 89.4 1.0
PCB-187 1,323 1.6–10.5 66.1 1.0
PCB-189 1,320 0.6–10.5 0.23 0.00003
PCB-194 1,309 1.6–10.5 60.9 1.0
PCB-196 1,318 1.6–10.5 54.8 1.0
PCB-199 1,311 1.6–10.5 58.4 1.0
Dioxins
2,3,7,8-TCDD 1,137 0.4–5.7 11.7 1.0
1,2,3,7,8-PeCDD 1,142 1.0–5.9 33.1 1.0
1,2,3,4,7,8-HxCDD 1,145 1.3–8.9 33.7 0.1
1,2,3,6,7,8- HxCDD 1,140 2.0–8.6 92.7 0.1
1,2,3,7,8,9- HxCDD 1,144 1.3–9.3 40.4 0.1
1,2,3,4,6,7,8-HpCDD 1,128 2.7–9.6 98.6 0.01
1,2,3,4,6,7,8,9-OCDD 1,083 52.0–318.8 80.8 0.0003
Furans
2,3,7,8-TCDF 1,137 0.4–5.2 0.8 0.1
1,2,3,7,8-PeCDF 1,141 0.4–5.8 0.7 0.03
2,3,4,7,8- PeCDF 1,137 1.0–5.8 64.5 0.3
1,2,3,4,7,8-HxCDF 1,132 1.4–6.4 81.1 0.1
1,2,3,6,7,8- HxCDF 1,143 1.1–6.1 68.3 0.1
1,2,3,7,8,9- HxCDF 1,130 0.6–5.9 0.1 0.1
2,3,4,6,7,8- HxCDF 1,136 1.0–5.8 11.0 0.1
1,2,3,4,6,7,8-HpCDF 1,126 1.3–6.9 89.4 0.01
1,2,3,4,7,8,9-HpCDF 1,131 0.7–6.9 0.1 0.01
Abbreviations: HpCDD, heptachlorodibenzo-p-dioxin; HpCDF, heptachlorodibenzofuran; HxCDD, hexachlorodibenzo-p-
dioxin; HxCDF, hexachlorodibenzofuran; LOD, limit of detection; OCDD, octachlorodibenzo-p-dioxin; PCB, polychlorinated 
biphenyl; PeCDD, pentachlorodibenzo-p-dioxin; PeCDF, pentachlorodibenzofuran; TCDD, tetrachlorodibenzo-p-dioxin; 
TCDF, tetrachloro dibenzofuran; TEQ, toxic equivalent.
aLODs are represented as a range because they vary by sample volume, which differed among participants. bUnits are 
picograms per gram lipid for PCB-126, PCB-169, dioxins, and furans; and nanograms per gram lipid for other PCBs.
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quartiles, percent differences were calcu-
lated using the formula {[e(β) – 1] × 100%}, 
with 95% CIs estimated as {[e(β ± 2.131 × SE) 
– 1] × 100}, where β and SE are the esti-
mated regression coefficient and the standard 
error, respectively. Percent differences were 
estimated by comparing each of the upper 
three quartiles with the lowest quartile, 
and tests for linear trends were conducted 
by modeling quartiles as an ordinal variable. 
The degrees of freedom were calculated by 
subtracting the number of clusters in the first 
level of sampling (strata) from the number of 
clusters [primary sampling units (PSUs)] in 
the second level of sampling [CDC/National 
Center for Health Statistics (NCHS) 2011]. 
Our study sample had 15 degrees of freedom, 
so we used a critical value of ±2.131 from 
the t distribution for the calculation of confi-
dence intervals. All analyses were adjusted for 
the sampling design of the NHANES survey 
using the 2-year dioxin subsample weights. 
A (two-sided) p-value < 0.05 was considered 
statistically significant.
To further differentiate the effects of 
congeners with AhR affinity from those 
without AhR affinity, we included a second 
exposure metric in the final, adjusted multi-
variable models of each exposure. Specifically, 
models of association of non–dioxin-like PCBs 
were additionally adjusted for non-ortho 
PCBs, and models of non-ortho PCBs and 
TEQ were additionally adjusted for non–
dioxin-like PCBs. These adjustments were 
made because the non–dioxin-like metric is 
highly correlated with both the non-ortho 
PCBs and TEQ (Pearson correlations of 
0.77 and 0.79, respectively, both p < 0.01). 
Therefore, the non–dioxin-like PCBs may 
confound the association between the other 
metrics and LTL; similarly, the other metrics 
may confound the association between 
non–dioxin-like PCBs and LTL. Because the 
metrics have different AhR affinities, including 
the second metric with different AhR affinity 
controlled for this potential confounding. We 
also used these multivariate models to test for 
interaction by age, sex, race/ethnicity, and 
cancer diagnosis. In these models, age was 
categorized into three groups (20–39, 40–59, 
≥ 60), and race/ethnicity was categorized into 
four groups as described above. Interactions 
were assessed for statistical significance using 
the p-value associated with the F statistic 
for the product term created by multiplying 
each categorical covariate by the natural log–
transformed continuous exposure metric. 
Participants answering, “Yes,” to the question, 
“Have you ever been told by a doctor or other 
health care professional that you had cancer or 
a malignancy of any kind?” were recorded as 
having a cancer diagnosis.
In addition to the main analyses, we 
conducted several sensitivity analyses to ensure 
that the values below the LOD, which consti-
tuted the majority of the data for some conge-
ners, did not affect the overall results. We 
modeled TEQ in two additional ways: first, 
we included only congeners that were detected 
in > 50% of the samples (n = 11); second, we 
included only congeners that were detected 
in > 33% of the samples (n = 14). We also 
used multiple imputation to generate values 
for all observations that were below the LOD 
in each congener, assuming that the values 
fell between zero and LOD divided by the 
square root of 2 for each congener and that 
the congeners were log-normally distributed. 
We averaged the results of five runs of the 
lifereg model in SAS v.9.3 (SAS Institute Inc., 
Cary, NC) to generate the imputed values. 
Only congeners with ≥ 10% of values detected 
were imputed to ensure valid imputation; for 
congeners with < 10% of values detected, the 
sample-specific LOD divided by the square 
root of 2 was used for < LOD values.
A second sensit ivity analys is  was 
performed to assess the effects of lipid adjust-
ment because dividing serum POPs by serum 
lipids could introduce bias if the serum lipids 
were associated with LTL (Schisterman et al. 
2005). Because NHANES 2001–2002 does 
not provide lipid concentrations as a separate 
variable, serum lipids were calculated by 
dividing each congener’s lipid-adjusted value 
by its wet-weight value for all values above the 
LOD. The final serum lipid value assigned to 
each participant was the average of the lipids 
calculated from PCB-74, PCB-138, PCB-153, 
PCB-180, and 1,2,3,4,6,7,8-heptachloro-
dibenzo-p-dioxin ratios. Fifteen participants 
had no measured congeners above the LOD, 
and their lipid levels were marked as missing. 
Multivariable models were run using congener 
wet-weight values, including serum lipids as a 
separate variable in the model. 
Results
Eighteen of the 34 PCBs (53%) were eligible 
for inclusion in the summed exposure metrics 
(Table 1). LTL was positively associated with 
serum cotinine and inversely associated with 
age (Table 2). Participants with < high school 
education had shorter LTL than those with 
more education; participants with BMI 
< 25 had longer LTL than those with higher 
BMIs (Table 2). LTL was shorter in white 
participants and longer in Mexican American 
Table 2. Demographic characteristics and leukocyte telomere length (T/S ratio × 100) in the study popula-





(T/S ratio × 100) 
geometric mean (95% CI)a
Whole population 106.6 (105.5, 107.6)
Serum cotinine (ng/mL)
< 0.015 19.0 (2.9) 104.1 (101.8, 106.4)**
0.015–9.90 50.9 (2.7) 106.0 (104.9, 107.2)
≥ 9.91 30.1 (1.6) 109.1 (108.0, 110.2)
Age (years)
20–39 42.3 (2.4) 117.8 (112.2, 123.4)**
40–59 38.2 (1.7) 107.2 (101.6, 112.7)
≥ 60 19.5 (1.5) 92.9 (89.3, 96.5)
Sex
Male 49.3 (1.6) 106.8 (105.4, 108.2)
Female 50.7 (1.6) 106.3 (105.4, 107.2)
Race/ethnicity
Non-Hispanic white 73.3 (2.9) 105.5 (104.2, 106.8)**
Non-Hispanic black 10.3 (2.1) 108.5 (107.2, 109.8)
Mexican American 7.0 (0.8) 111.3 (110.6, 112.0)
Other 9.4 (2.0) 109.3 (107.7, 111.0)
Education
< High school 19.8 (1.5) 105.4 (103.6, 107.2)*
High school graduate 24.3 (1.1) 106.8 (104.7, 108.8)
Some college 30.4 (2.1) 107.6 (106.2, 109.1)
≥ College graduate 25.5 (1.8) 106.0 (104.9, 107.1)
BMI (kg/m2)
< 25 34.8 (0.9) 108.3 (107.3, 109.2)**
25–29.9 35.6 (1.4) 105.7 (104.3, 107.1)
≥ 30 29.7 (1.6) 105.6 (104.1, 107.1)
Cancer diagnosisb
No 91.2 (1.1) 107.4 (106.4, 108.4)**
Yes 8.8 (1.1) 97.6 (95.0, 100.2)
Abbreviations: BMI, body mass index; CI, confidence interval; LTL, leukocyte telomere length; NHANES, National Health 
and Nutrition Examination Survey; SE, standard error.
aLTL is adjusted for continuous age, except for the LTL values in the age group categories. bTwo participants were 
missing data on cancer diagnosis (n = 1,328). Participants answering “Yes” to the question, “Have you ever been told by 
a doctor or other health care professional that you had cancer or a malignancy of any kind?” were recorded as having 
a cancer diagnosis. p-Values were calculated using analysis of variance (ANOVA) tests within each demographic 
category. *p < 0.05. **p < 0.01.
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participants, and it was shorter in people with 
a cancer diagnosis (Table 2). Levels of non–
dioxin-like PCBs, non-ortho PCBs, and TEQ 
were significantly positively associated with 
age, and levels of non-ortho PCBs and TEQ 
were significantly negatively associated with 
serum cotinine (Table 3). Mexican American 
participants had the lowest levels of non–
dioxin-like PCBs, non-ortho PCBs, and TEQ 
(Table 3). Participants with a cancer diagnosis 
had higher levels of PCBs, non-ortho PCBs, 
and TEQ (Table 3).
Exposure to non-ortho PCBs was associ-
ated with longer LTL. Each doubling of the 
non-ortho PCB metric was associated with 
3.74% (95% CI: 2.10, 5.40) longer LTL in 
fully adjusted models (Table 4, Model 3). 
In quartile models, the highest (vs. lowest) 
quartile of exposure was associated with 
9.16% (95% CI: 2.96, 15.73) longer LTL 
(p for trend = 0.0036, Table 4, Model 3). 
The association was slightly stronger in 
models without adjustment for non–dioxin-
like PCBs (Table 4, Model 2). In those 
models, each doubling of non–ortho-PCBs 
was associated with 4.31% (95% CI: 
2.76, 5.88) longer LTL (p for trend = 0.0011, 
Table 4, Model 2).
Exposure to TEQ was also associated 
with longer LTL. Each doubling of the TEQ 
metric was associated with 5.29% (95% CI: 
1.66, 9.05) longer LTL in fully adjusted 
models (Table 4, Model 3). In quartile 
models, the association was not significant. 
The highest (vs. lowest) quartile of exposure 
was associated with 7.84% (95% CI: 
Table 3. Lipid-adjusted serum pollutant levels by summed metric in NHANES 2001–2002. 
Variable
Non–dioxin-like PCBs 
(ng/g lipid)  
(n = 1,273)
Non-ortho PCBs 





Whole population 136.9 (125.4, 149.4) 43.3 (39.7, 47.3) 18.6 (17.1, 20.2)
Serum cotinine (ng/mL)
< 0.015 154.0 (125.8, 188.4) 50.5 (43.4, 58.8)** 20.2 (17.7, 23.1)**
0.015–9.9 137.6 (125.8, 150.4) 46.7 (42.9, 50.8) 19.4 (17.7, 21.2)
≥ 9.91 125.7 (113.0, 139.7) 34.3 (29.8, 39.5) 16.4 (14.8, 18.3)
Age (years)
20–39 76.6 (70.5, 83.1)** 27.7 (24.8, 31.0)** 13.6 (12.7, 14.7)**
40–59 171.4 (156.7, 187.6) 49.3 (45.7, 53.2) 19.3 (17.7, 20.9)
≥ 60 309.4 (294.0, 325.5) 84.7 (78.4, 91.5) 32.8 (29.5, 36.6)
Sex
Male 137.8 (123.4, 153.8) 43.5 (39.2, 48.4) 18.3 (16.9, 19.9)
Female 136.1 (126.0, 147.0) 43.2 (39.6, 47.0) 18.8 (17.1, 20.6)
Race/ethnicity
Non-Hispanic white 147.2 (133.4, 162.4)** 45.5 (41.4, 50.0)** 19.3 (17.6, 21.1)**
Non-Hispanic black 157.4 (142.0, 174.4) 42.9 (38.4, 48.1) 20.4 (18.7, 22.2)
Mexican American 71.3 (67.4, 75.5) 29.3 (26.9, 31.9) 14.0 (13.4, 14.5)
Other 109.4 (88.6, 135.2) 40.6 (32.2, 51.2) 16.1 (14.0, 18.4)
Education
< High school 136.9 (117.5, 159.6) 40.9 (35.2, 47.4) 19.4 (16.9, 22.2)
High school graduate 133.9 (116.9, 153.3) 43.3 (39.4, 47.5) 19.4 (17.4, 21.6)
Some college 130.4 (117.4, 145.0) 42.7 (38.0, 48.0) 17.9 (16.6, 19.3)
≥ College graduate 148.1 (129.8, 169.1) 46.2 (38.9, 54.9) 17.9 (16.2, 19.8)
BMI (kg/m2)
< 25 140.5 (126.6, 155.9) 42.1 (38.6, 45.9) 18.9 (17.6, 20.4)
25–29.9 138.6 (125.3, 153.4) 42.5 (37.3, 48.3) 17.9 (16.1, 19.9)
≥ 30 130.9 (114.2, 149.9) 45.9 (40.9, 51.6) 19.1 (17.1, 21.4)
Cancer diagnosisa
Yes 208.1 (184.3, 235.0)** 60.2 (51.0, 71.1)** 25.3 (21.6, 29.7)**
No 131.7 (121.1, 143.1) 41.9 (38.5, 45.6) 18.0 (16.7, 19.4)
Abbreviations: BMI, body mass index; NHANES, National Health and Nutrition Examination Survey; PCB, polychlorinated 
biphenyl; TEQ, toxic equivalent. p-Values were calculated using analysis of variance (ANOVA) tests within each demo-
graphic category. Reported values are geometric means and 95% confidence intervals. All analyses were adjusted for 
NHANES sample weights.
aTwo participants were missing data on cancer diagnosis. Participants answering “Yes” to the question, “Have you 
ever been told by a doctor or other health care professional that you had cancer or a malignancy of any kind?” were 
recorded as having a cancer diagnosis. **p < 0.01.
Table 4. Percent difference (95% CI) in leukocyte telomere length (T/S ratio) by non–dioxin-like PCBs, non-ortho PCBs, and the toxic equivalent (TEQ). 
Metric n
Model 1a  
percent difference (95% CI) n
Model 2b  




Per doubling of exposure 1,273 4.09 (1.16, 7.11)** 1,267 3.80 (0.80, 6.90)* 1,094 0.42 (–2.39, 3.32)
Quartile 1 (≤ 74.6 ng/g) Reference Reference Reference
Quartile 2 (74.7–135.9 ng/g) 3.50 (–3.13, 10.58) 3.04 (–3.19, 9.67) 0.53 (–4.96, 6.33)
Quartile 3 (136.0–245.2 ng/g) 7.68 (1.52, 14.22)* 7.20 (1.49, 13.23)* 1.21 (–3.75, 6.43)
Quartile 4 (> 245.2 ng/g) 10.55 (2.07, 19.74)* 9.40 (0.88, 18.64)* 0.84 (–5.37, 7.45)
p trend 0.0091** 0.019* 0.74
Non-ortho PCBs
Per doubling of exposure 1,135 4.26 (2.42, 6.14)** 1,129 4.31 (2.76, 5.88)** 1,094 3.74 (2.10, 5.40)**
Quartile 1 (≤ 26.8 pg/g) Reference Reference Reference
Quartile 2 (26.9–44.7 pg/g) 0.94 (–3.90, 6.17) 0.85 (–3.96, 5.89) 1.30 (–3.66, 6.53)
Quartile 3 (44.8–71.5 pg/g) 6.45 (1.80, 11.30)** 6.17 (2.15, 10.35)** 5.21 (0.92, 9.68)*
Quartile 4 (> 71.5 pg/g) 10.60 (3.29, 18.44)** 10.63 (3.98, 17.71)** 9.16 (2.96, 15.73)**
p trend 0.0029** 0.0011** 0.0036**
TEQ 
Per doubling of exposure 1,003 5.59 (1.99, 9.31)** 999 5.76 (2.27, 9.37)** 976 5.29 (1.66, 9.05)**
Quartile 1 (≤ 12.7 pg/g) Reference Reference Reference
Quartile 2 (12.8–17.3 pg/g) 1.45 (–3.06, 6.17) 2.05 (–2.71, 7.05) 1.43 (–3.41, 6.52)
Quartile 3 (17.4–25.3 pg/g) 3.71 (–3.63, 11.60) 4.11 (–3.11, 11.88) 3.25 (–4.04, 11.10)
Quartile 4 (> 25.3 pg/g) 9.37 (1.55, 17.79)* 9.23 (1.28, 17.80)* 7.84 (–0.53, 16.92)
p trend 0.048* 0.051 0.11
Abbreviations: CI, confidence interval; NHANES, National Health and Nutrition Examination Survey; PCB, polychlorinated biphenyl. All analyses were adjusted for NHANES 
sample weights.
aModel 1 is adjusted for age, age2. bModel 2 is adjusted for age, age2, sex, race/ethnicity, BMI, log(cotinine), white blood cell count, percent lymphocytes, percent monocytes, percent 
neutrophils, percent eosinophils, percent basophils. cModel 3 is additionally adjusted for a second exposure metric. Non–dioxin-like PCBs are adjusted for non-ortho PCBs. Non-ortho 
PCBs and TEQ are adjusted for non–dioxin-like PCBs. *p < 0.05. **p < 0.01.
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–0.53, 16.92) longer LTL (p for trend = 0.11, 
Table 4, Model 3). The association was 
slightly stronger in models without adjust-
ment for non–dioxin-like PCBs (Table 4, 
Model 2). In those models, each doubling of 
TEQ was associated with 5.76% (95% CI: 
2.27, 9.37) longer LTL (p for trend = 0.051, 
Table 4, Model 2).
Exposure to non–dioxin-like PCBs was 
not associated with longer LTL after adjust-
ment for non-ortho PCBs. In fully adjusted 
models, each doubling of the non–dioxin-
like PCBs metric was associated with 0.42% 
(95% CI: –2.39, 3.32) longer LTL (Table 4, 
Model 3). Quartiles of non–dioxin-like PCBs 
were also not associated with LTL (Table 4, 
Model 3). However, in models that were not 
adjusted for non-ortho PCBs, each doubling 
of non–dioxin-like PCBs was associated with 
3.80% (95% CI: 0.80, 6.90) longer LTL, and 
in quartile models, the highest (vs. lowest) 
quartile of exposure was associated with 
9.40% (95% CI: 0.88, 18.64) longer LTL (p 
for trend = 0.019, Table 4, Model 2).
Tests for interaction by age, sex, and 
cancer diagnosis were not significant 
(Figure 1). Tests for interaction by race/
ethnicity were not significant for non–
dioxin-like PCBs or non-ortho PCBs 
but were signifi cant for TEQ (p < 0.01, 
Figure 1). Exposure to TEQ was associated 
with significantly longer LTL among non-
Hispanic whites and non-Hispanic blacks, 
but it was associated with significantly shorter 
LTL among Mexican Americans (Figure 1). 
Figure 1 p-values were derived from linear 
regression models with multiplicative inter-
action terms; percent difference estimates were 
generated from stratified models.
Sensitivity analyses examining the effects 
of the treatment of data below the LOD on 
the overall results did not meaningfully alter 
the findings (see Supplemental Material, 
Table S1). Models based on congener wet 
weights, adjusting for serum lipids as a separate 
covariate, largely showed the same pattern of 
results as the models that used lipid-adjusted 
values (see Supplemental Material, Table S2).
Discussion
In this analysis, exposure to non-ortho PCBs 
and TEQ was associated with longer LTL 
even after adjustment for non–dioxin-like 
PCB exposure. Exposure to non–dioxin-like 
PCBs was no longer associated with LTL after 
adjustment for non-ortho PCB exposure. 
Each doubling of exposure to non-ortho 
PCBs or TEQ was associated with 3–6% 
longer LTL in fully adjusted models (p < 0.01 
for both exposures). Non-ortho PCBs were 
also associated with longer LTL in quartile 
models, with evidence of positive dose–
response (p for trend = 0.0036). TEQ quartile 
models were suggestive of positive, monotonic 
dose–response, but after adjustment for non–
dioxin-like PCBs, the trend failed to reach 
significance (p for trend = 0.11) despite the 
significant association in continuous models.
Our results suggest that the strength of the 
association varies by congener TEF. Exposure 
to non-ortho PCBs and TEQ (with high TEFs 
and AhR affinity) were associated with longer 
LTL in linear models even after adjustment 
for exposure to non–dioxin-like PCBs, which 
have no AhR affinity. However, non–dioxin-
like PCBs were not associated with LTL after 
adjustment for non-ortho PCBs. These results 
align well with those of a previous epidemio-
logical study that investigated this association 
in PCBs (Shin et al. 2010) as well as with 
preliminary in vitro data suggesting that AhR 
activation can activate telomerase, thereby 
elongating LTL (Sarkar et al. 2006).
Although both non-ortho PCBs and TEQ 
were associated with longer LTL in linear 
models, the positive dose–response relation-
ship was weaker for TEQ when exposure was 
modeled as quartiles. The TEQ metric incor-
porated congeners with very strong as well as 
very weak TEFs and AhR affinity, and this 
heterogeneity may have increased the error 
when estimating the effect of the metric. 
Alternatively, the pattern of results may be due 
to the greater prevalence of undetected values 
in the TEQ metric, which would be expected 
to introduce random error, especially in the 
lower quartiles. The potential also exists for 
mutual confounding between the two metrics; 
this was not tested in the present analysis.
The relationship between LTL and cancer 
is complicated, varying by cancer type and 
sometimes by demographic characteristics, 
such as age of the cancer patient or duration 
between LTL measurement and cancer diag-
nosis (Boardman et al. 2014; Hou et al. 2015). 
In general, shorter LTL appears to increase 
cancer risk (Willeit et al. 2010). However, 
many cancers linked to dioxin exposure have 
been associated with longer LTL in multiple 
epidemiological studies; these cancers include 
lung cancer (Sanchez-Espiridion et al. 2014; 
Seow et al. 2014), soft tissue sarcoma (Xie 
et al. 2013), and non-Hodgkin lymphoma 
(Lan et al. 2009). In fact, among 20 published 
studies investigating the association between 
PCB/dioxin-related cancer risk and LTL, 15 
reported positive associations, largely based on 
tertile or quartile trend tests (see Supplemental 
Material, Table S3). The role of telomere 
biology in dioxin carcinogenesis warrants 
further research in both experimental and 
observational studies.
Figure 1. Association between persistent organic pollutants (POPs) metric exposure and leukocyte 
telomere length (LTL) in the general U.S. population. Percent difference estimates were generated from 
stratified models. p-Values were derived from linear regression models with multiplicative interaction 
terms for age [non–dioxin-like pinteraction = 0.14; non-ortho pinteraction = 0.80; toxic equivalent (TEQ) 
pinteraction = 0.87]; sex (non–dioxin-like pinteraction = 0.18; non-ortho pinteraction = 0.23; TEQ pinteraction = 0.13); 
race (non–dioxin-like pinteraction = 0.21; non-ortho pinteraction = 0.19; TEQ pinteraction < 0.01); and cancer status 
(non–dioxin-like pinteraction = 0.72; non-ortho pinteraction = 0.68; TEQ pinteraction = 0.37). Regression models 
were adjusted for age, age2, sex, race/ethnicity, body mass index (BMI), log(cotinine), white blood cell 
count, percent lymphocytes, percent monocytes, percent neutrophils, percent eosinophils, percent 
basophils. Non–dioxin-like polychorinated biphenyls (PCBs) were adjusted for non-ortho PCBs. Non-ortho 
PCBs and TEQ were adjusted for non–dioxin-like PCBs. Data points represent percent difference in LTL 
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To explore the possible connections 
among dioxins, LTL, and cancer in this 
population, we tested for effect modification 
by cancer diagnosis. However, the statistical 
interaction was not significant, and the asso-
ciations were comparable between those with 
a previous cancer diagnosis and those without 
a diagnosis. Our analysis by cancer diagnosis 
was limited by the small number of partici-
pants with a cancer diagnosis, the lack of 
information on clinical characteristics of the 
cancer cases, an inability to divide the analysis 
by cancer type, potential clinical heteroge-
neity among the cancer cases, and variability 
in time since cancer diagnosis. The rela-
tionship between POPs and LTL in cancer 
patients should be examined in future studies.
This study had several important strengths. 
Because we used NHANES data, we were 
able to examine these associations in a large 
population. Additionally, NHANES collected 
precise data on serum concentrations of 51 
PCBs, dioxins, and furans, which allowed us 
to accurately assess each participant’s exposure 
to a range of relevant POPs, to group conge-
ners according to shared biochemical char-
acteristics, and to control for simultaneous 
exposure to multiple congeners. Finally, we 
were able to control for multiple possible 
demographic and chemical confounders, 
including blood cell count and distribution.
However, this study was also subject to 
limitations. The cross-sectional design of 
NHANES prevents us from making causal 
inference or establishing a temporal relation-
ship between PCB, dioxin, or furan exposure 
and LTL. Additionally, many of the dioxins 
and furans measured by NHANES were 
detected in very low levels in most partici-
pants, limiting the number of observations 
above the LOD and thereby reducing preci-
sion in the lower TEQ quartiles. We did not 
adjust for missingness probabilities in the 
data, so our sample may have been biased 
because participants who did not consent to 
use of their DNA were nonrandom. Finally, 
the strong association between age and 
serum levels of each pollutant likely reflects 
two different age-varying factors: a) much 
higher exposures historically (before these 
chemicals were banned); and b) accumula-
tion and persistence of these chemicals in the 
human body over time. Older participants 
were therefore exposed at a higher level, for a 
longer period of time, than younger partici-
pants. Our findings may have been affected 
by our inability to fully model these age-
specific effects despite our inclusion of age 
(and age2) terms in the regression models.
Conclusions
Our analysis shows that exposure to non-
ortho PCBs and TEQ was associated with 
increased LTL in our study population of U.S. 
adults, contributing population-level findings 
to the evidence that exposure to environ-
mental contaminants may influence telomere 
regulation. This association was not seen for 
exposure to non–dioxin-like PCBs, suggesting 
that the pattern of results may be driven by 
the congeners’ varying relative potency and 
affinity for the AhR. Because many dioxin-
associated cancers are also associated with 
increased LTL, these results may provide 
insight into the mechanisms underlying PCB- 
and dioxin-related carcinogenesis. Future 
research is needed to better understand the 
complex role LTL may play in cancer.
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